Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-26

Clinical Trial Update: Lycopene In Preventing of Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial investigating lycopene for the prevention of prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lycopene (lycopene)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED